Integrated NAMs Platform ASLS combines automated hardware, intelligent software, and expert services to deliver human relevant NAMs friendly platforms for automated 3D tissue and organoid assembly, vascularization, and tissue modeling. This integrated stack enables scalable, reproducible research and helps labs shorten discovery timelines while reducing reliance on animal models.

Award Winning Credibility The company has earned multiple Product of the Year recognitions for its BioAssembly Bot and AI powered tissue and bone fabrication capabilities, strengthening credibility with potential customers and supporting faster decision making when evaluating automation investments.

Turnkey Organoid Solutions Organoid360 Bundle provides a bench ready turnkey solution for organoid agnostic workflows alongside professional services and custom workflows, making it easier for mid sized labs to adopt 3D tissue and organoid research without building bespoke infrastructure.

Strategic Partnerships Existing collaborations with Molecular Devices signal a healthy ecosystem approach and create opportunities to cross-sell and integrate ASLS platforms within pharma, biotech, and CRO environments seeking scalable automation and compatible hardware software ecosystems.

Growth Opportunity Louisville based ASLS operates with a lean team and a growing NAMs product line spanning automation, software, and services, presenting an opportunity to expand geographically and into translational research verticals as demand for human relevant models increases.